These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34998574)

  • 21. Corrigendum to "Eucalyptal A inhibits glioma by rectifying oncogenic splicing of MYO1B mRNA via suppressing SRSF1 expression" [Eur. J. Pharmacol. (2021) 890 173669].
    Hua D; Zhao Q; Yu Y; Yu H; Yu L; Zhou X; Wang Q; Sun C; Shi C; Luo W; Jiang Z; Wang W; Wang L; Zhang D; Tang S; Yu S
    Eur J Pharmacol; 2022 Apr; 921():174897. PubMed ID: 35292175
    [No Abstract]   [Full Text] [Related]  

  • 22. Corrigendum to "N-arachidonoylphenolamine alleviates ischaemia/reperfusion-induced cardiomyocyte necroptosis by restoring proteasomal activity" [Eur. J. Pharmacol. (2024) 963 176235].
    Bai JQ; Li PB; Li CM; Li HH
    Eur J Pharmacol; 2024 Feb; 965():176316. PubMed ID: 38216371
    [No Abstract]   [Full Text] [Related]  

  • 23. Corrigendum to "Magnesium isoglycyrrhizinate blocks fructose-induced hepatic NF-κB/NLRP3 inflammasome activation and lipid metabolism disorder" [Eur. J. Pharmacol. 15 (2017) 809: 141-150].
    Zhao XJ; Yang YZ; Zheng YJ; Wang SC; Gu HM; Pan Y; Wang SJ; Xu HJ; Kong LD
    Eur J Pharmacol; 2021 Oct; 909():174440. PubMed ID: 34450555
    [No Abstract]   [Full Text] [Related]  

  • 24. Corrigendum to "Essential role of Ca
    Tsubota M; Matsui K; Nakano M; Kajitani R; Ishii Y; Tomochika K; Nishikawa Y; Fukushi S; Yamagata A; Sekiguchi F; Okada T; Toyooka N; Kawabata A
    Eur J Pharmacol; 2021 Feb; 892():173795. PubMed ID: 33358247
    [No Abstract]   [Full Text] [Related]  

  • 25. Corrigendum to "SUMO2-mediated SUMOylation of SH3GLB1 promotes ionizing radiation-induced hypertrophic cardiomyopathy through mitophagy activation"[Eur. J. Pharmacol. 924 (2022) 174980].
    Gao A; Zou J; Mao Z; Zhou H; Zeng G
    Eur J Pharmacol; 2024 Apr; 968():176456. PubMed ID: 38395694
    [No Abstract]   [Full Text] [Related]  

  • 26. Corrigendum to 'Antitumor effects of seleno-β-lactoglobulin (Se-β-Lg) against human gastric cancer MGC-803 cells' [Eur. J. Pharmacol. 833 (2018) 109-115].
    Yu J; Dong X; Wang LL; Ji H; Liu A
    Eur J Pharmacol; 2019 Mar; 846():128-130. PubMed ID: 30409420
    [No Abstract]   [Full Text] [Related]  

  • 27. Corrigendum to "A novel flavonoid isolated from the steam-bark of Ulmus wallichiana planchon stimulates osteoblast function and inhibits osteoclast and adipocyte differentiation" [Eur. J. Pharmacol. 658(2-3) 2011 65-73].
    Swarnkar G; Sharan K; Siddiqui J; Chakravarti B; Rawat P; Kumar M; Arya KR; Maurya R; Chattopadhyay N
    Eur J Pharmacol; 2018 Jul; 831():103-105. PubMed ID: 29803358
    [No Abstract]   [Full Text] [Related]  

  • 28. Corrigendum to: "Long-term leptin treatment exerts a pro-apoptotic effect on renal tubular cells via prostaglandin E2 augmentation" [Eur. J. Pharmacol. 689 (2012) 65-71].
    Hsu YH; Cheng CY; Chen YC; Chen TH; Sue YM; Tsai WL; Chen CH
    Eur J Pharmacol; 2016 Dec; 792():79. PubMed ID: 27916229
    [No Abstract]   [Full Text] [Related]  

  • 29. Corrigendum to "α-Conidendrin inhibits the expression of intercellular adhesion molecule-1 induced by tumor necrosis factor-α in human adenocarcinoma A549 cells" [Eur. J. Pharmacol. 890 (2021) 173651].
    Vo NT; Sasaki S; Miyake Y; Nguyen NT; Dang PH; Thi Nguyen MT; Kataoka T
    Eur J Pharmacol; 2021 Oct; 909():174453. PubMed ID: 34462123
    [No Abstract]   [Full Text] [Related]  

  • 30. Corrigendum to "The Ω-3 fatty acid docosahexaenoic acid selectively induces apoptosis in tumor-derived cells and suppress tumor growth in gastric cancer" [Eur. J. Pharmacol. (2021) 173910].
    Ortega L; Lobos-González L; Reyna-Jeldes M; Cerda D; De la Fuente-Ortega E; Castro P; Bernal G; Coddou C
    Eur J Pharmacol; 2021 Sep; 906():174287. PubMed ID: 34183147
    [No Abstract]   [Full Text] [Related]  

  • 31. Corrigendum to "Diethyl-4,4'-dihydroxy-8,3'-neolign-7,7'-dien-9,9'-dionate exhibits antihypertensive activity in rats through increase in intracellular cGMP level and blockade of calcium channels" [Eur. J. Pharmacol. 799 (2017) 84-93].
    Singh A; Kumar BS; Alam S; Iqbal H; Shafiq M; Khan F; Negi AS; Hanif K; Chanda D
    Eur J Pharmacol; 2017 Jul; 806():111. PubMed ID: 28495016
    [No Abstract]   [Full Text] [Related]  

  • 32. Corrigendum to "D-578, an orally active triple monoamine reuptake inhibitor, displays antidepressant and anti-PTSD like effects in rats" [Eur. J. Pharmacol. 862 (2019) 172632].
    Dutta AK; Santra S; Harutyunyan A; Das B; Lisieski MJ; Xu L; Antonio T; Reith MEA; Perrine SA
    Eur J Pharmacol; 2022 Oct; 933():175286. PubMed ID: 36167739
    [No Abstract]   [Full Text] [Related]  

  • 33. Corrigendum to "D-578, an orally active triple monoamine reuptake inhibitor, displays antidepressant and anti-PTSD like effects in rats" [Eur. J. Pharmacol. 862 (2019) 172632-172640].
    Dutta AK; Santra S; Harutyunyan A; Das B; Lisieski MJ; Xu L; Antonio T; Reith MEA; Perrine SA
    Eur J Pharmacol; 2022 Sep; 931():175232. PubMed ID: 36038378
    [No Abstract]   [Full Text] [Related]  

  • 34. Corrigendum to "Exenatide ameliorates hydrogen peroxide-induced pancreatic β-cell apoptosis through regulation of METTL3-mediated m
    Zhou S; Sun Y; Xing Y; Wang Z; Wan S; Yao X; Hua Q; Meng X; Cheng J; Zhong M; Lv K; Kong X
    Eur J Pharmacol; 2023 May; 946():175652. PubMed ID: 36924576
    [No Abstract]   [Full Text] [Related]  

  • 35. Corrigendum to "Chloroquine modulates the sulforaphane anti-obesity mechanisms in a high-fat diet model: Role of JAK-2/ STAT-3/ SOCS-3 pathway" [Eur. J. Pharmacol. (2022) 927:175066].
    Ashmawy AI; El-Abhar HS; Abdallah DM; Ali MA
    Eur J Pharmacol; 2023 May; 947():175683. PubMed ID: 36997461
    [No Abstract]   [Full Text] [Related]  

  • 36. Corrigendum to 'Echinocystic acid, a natural plant extract, alleviates cerebral ischemia/reperfusion injury via inhibiting the JNK signaling pathway' [Eur. J. Pharmacol., 861 (2019 oct 15), 172610].
    Yu H; Li W; Cao X; Wang X; Zhao Y; Song L; Chen J; Wang S; Chen B; Xu Y
    Eur J Pharmacol; 2021 Feb; 892():173790. PubMed ID: 33308992
    [No Abstract]   [Full Text] [Related]  

  • 37. Corrigendum to "Odd-skipped related transcription factor 1 (OSR1) suppresses tongue squamous cell carcinoma migration and invasion through inhibiting NF-κB pathway" [Eur. J. Pharmacol. 15 (2018) 33-39].
    Chen W; Wu K; Zhang H; Fu X; Yao F; Yang A
    Eur J Pharmacol; 2019 Mar; 847():158. PubMed ID: 30529035
    [No Abstract]   [Full Text] [Related]  

  • 38. Corrigendum to 'Reduced nitric oxide-mediated relaxation and endothelial nitric oxide synthase expression in the tail arteries of streptozotocin-induced diabetic rats' [Eur. J. Pharmacol. 773 (2016) 78-84].
    Mokhtar SS; Vanhoutte PM; Leung SWS; Suppian R; Yusof MI; Rasool AHG
    Eur J Pharmacol; 2017 Oct; 812():264. PubMed ID: 28915977
    [No Abstract]   [Full Text] [Related]  

  • 39. Corrigendum to "Tenuigenin exhibits protective effects against LPS-induced acute kidney injury via inhibiting TLR4/NF-κB signaling pathway" [Eur. J. Pharmacol. 791 (2016) 229-234].
    Haiyan F; Zhansheng H; Xingwei D; Qiuhong Z; Rongbin Z; Hongyang D
    Eur J Pharmacol; 2016 Dec; 792():78. PubMed ID: 27916228
    [No Abstract]   [Full Text] [Related]  

  • 40. Corrigendum to "Na(+)-dependent inactivation of vascular Na(+)/Ca(2+) exchanger responsible for reduced peripheral blood flow in neuropathic pain model" [Eur. J. Pharmacol. 910 (2021) 174448].
    Ishida H; Yamaguchi M; Saito SY; Furukawa T; Shannonhouse JL; Kim YS; Ishikawa T
    Eur J Pharmacol; 2024 May; 970():176495. PubMed ID: 38490839
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.